HEMOGENYX PHARMPLC (Germany) Price on September 27, 2024

5HU Stock  EUR 4.22  0.41  10.76%   
If you're considering investing in HEMOGENYX Stock, it is important to understand the factors that can impact its price. As of today, the current price of HEMOGENYX PHARMPLC stands at 4.22, as last reported on the 29th of December, with the highest price reaching 4.22 and the lowest price hitting 3.81 during the day. HEMOGENYX PHARMPLC is out of control given 3 months investment horizon. HEMOGENYX PHARMPLC holds Efficiency (Sharpe) Ratio of 0.13, which attests that the entity had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 16.4% are justified by taking the suggested risk. Use HEMOGENYX PHARMPLC LS 01 Semi Deviation of 17.29, risk adjusted performance of 0.1091, and Market Risk Adjusted Performance of 2.23 to evaluate company specific risk that cannot be diversified away.
  
HEMOGENYX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1265

Best PortfolioBest Equity5HU
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 129.58
  actual daily
96
96% of assets are less volatile

Expected Return

 5.01
  actual daily
96
96% of assets have lower returns

Risk-Adjusted Return

 0.13
  actual daily
9
91% of assets perform better
Based on monthly moving average HEMOGENYX PHARMPLC is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HEMOGENYX PHARMPLC by adding it to a well-diversified portfolio.

HEMOGENYX PHARMPLC Valuation on September 27, 2024

It is possible to determine the worth of HEMOGENYX PHARMPLC on a given historical date. On September 27, 2024 HEMOGENYX was worth 4.2 at the beginning of the trading date compared to the closed value of 5.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HEMOGENYX PHARMPLC stock. Still, in general, we apply an absolute valuation method to find HEMOGENYX PHARMPLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HEMOGENYX PHARMPLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HEMOGENYX PHARMPLC's related companies.
 Open High Low Close Volume
  5.40    6.00    5.40    6.00    1.00  
09/27/2024
  4.20    5.20    4.20    5.20    1.00  
  5.00    5.00    5.00    5.00    1.00  
Backtest HEMOGENYX PHARMPLC  |  HEMOGENYX PHARMPLC History  |  HEMOGENYX PHARMPLC Valuation   PreviousNext  
Open Value
4.2
5.2
Closing Value
392.94
Upside

HEMOGENYX PHARMPLC Trading Date Momentum on September 27, 2024

On September 30 2024 HEMOGENYX PHARMPLC LS 01 was traded for  5.00  at the closing time. The highest daily price throughout the period was 5.00  and the lowest price was  5.00 . There was no trading activity during the period 1.0. Lack of trading volume on 09/30/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 3.85% . The trading delta at closing time to current closing price is 19.23% .

HEMOGENYX PHARMPLC Fundamentals Correlations and Trends

By evaluating HEMOGENYX PHARMPLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HEMOGENYX PHARMPLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HEMOGENYX financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About HEMOGENYX PHARMPLC Stock history

HEMOGENYX PHARMPLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HEMOGENYX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HEMOGENYX PHARMPLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HEMOGENYX PHARMPLC stock prices may prove useful in developing a viable investing in HEMOGENYX PHARMPLC
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.

HEMOGENYX PHARMPLC Stock Technical Analysis

HEMOGENYX PHARMPLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of HEMOGENYX PHARMPLC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of HEMOGENYX PHARMPLC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

HEMOGENYX PHARMPLC Period Price Range

Low
December 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

HEMOGENYX PHARMPLC LS 01 cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

HEMOGENYX PHARMPLC December 29, 2024 Market Strength

Market strength indicators help investors to evaluate how HEMOGENYX PHARMPLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HEMOGENYX PHARMPLC shares will generate the highest return on investment. By undertsting and applying HEMOGENYX PHARMPLC stock market strength indicators, traders can identify HEMOGENYX PHARMPLC LS 01 entry and exit signals to maximize returns

HEMOGENYX PHARMPLC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for HEMOGENYX PHARMPLC's price direction in advance. Along with the technical and fundamental analysis of HEMOGENYX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HEMOGENYX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for HEMOGENYX Stock analysis

When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk